Author Archive: Jeremy Parkinson
AUD/USD Forecast Mar. 12-16
The Australian dollar managed to recover mostly thanks to hopes that the Trump tariffs are not so bad and despite not-so-great Australian data. Can it continue higher? Speeches by RBA members and an important Chinese figure stand out. Here are the highlights of the week and an updated technical analysis for AUD/USD. The Australian economy grew by […]
Above The 40 – Stock Market Returns To Its Originally Scheduled Program
AT40 = 48.5% of stocks are trading above their respective 40-day moving averages (DMAs)AT200 = 52.9% of stocks are trading above their respective 200DMAsVIX = 14.6 (11.5% drop)Short-term Trading Call: bullish Commentary The (expected) plunge in the volatility index, the VIX, says it all…the stock market is ready to return to its originally scheduled programming. The volatility index, […]
Anatomy Of Success: Nintendo (NTDOY)
When a company earns the coveted Zacks Rank #1 (Strong Buy), it is displaying the right characteristics to beat the market over the next one to three months. But of course, reaching this ideal rank is not an easy feat. Of the thousands of companies tracked by Zacks, only about 5% earn this designation. Below, […]
Trading Support And Resistance – March 11
This week we’ll begin with our monthly and weekly forecasts of the currency pairs worth watching. The first part of our forecast is based upon our research of the past 16 years of Forex prices, which show that the following methodologies have all produced profitable results: Trading the two currencies that are trending the most strongly over the […]
Why Investors Should Closely Watch The Oil Market
Oil’s price move in the upcoming weeks will be decisive for its overall performance in 2018. After our initial oil price target in 2018 was met recently, we published an oil price update where we mentioned that oil is not bearish, at least not from the long term perspective. Our outlook was based on the analysis of the […]
Investors Try On AI-based Drug Discovery With BioXcel
Last week BioXcel Therapeutics (Nasdaq: BTAI) went public at $11. It looks like a typical biotechnology company with two drugs (BXCL501 and BXCL701) in Phase 1/2 trials for mental disorders and cancer respectively. Both drugs look fairly promising based on the data presented and we’ll get to that. But BioXcel is taking a different approach to […]
Weekly Market Outlook – The Best And Worst Possible Kind Of Breakout
Despite last week’s bullish start, the buyers offered very little follow-through in the middle of the week. Too much political noise kept traders on the sidelines. That all changed on Friday though, and with very little prodding. Thanks to Friday’s 1.74% jump from the S&P 500, the index booked a gain of 3.5% for […]
Dow Jones And The Barron’s Gold Mining Index: A 98-Year Examination
Looking at the market at the close of this week, apparently the “policy makers” have once again gotten a handle on the financial markets. In the Dow Jones BEV chart below it did correct 10%; but only for one day, February 8, with the Dow Jones coming back since. It closed the week only 4.81% […]
EUR/USD Forecast Mar. 12-16 – At The Crossroads
EUR/USD had a turbulent week that it eventually ended slightly lower and it is still looking for a new direction. The upcoming week features a speech by Draghi, final inflation figures, and more. What’s next for EUR/USD? Here is an outlook for the highlights of this week and an updated technical analysis for EUR/USD. While Germany will […]
Gold From Soup To Nuggets
Gold’s change for the week just past? A zip-zero-nada bona fide nothing burger. Well, it did sport a net gain for the week of 30¢ having settled the prior Friday at 1323.7 and now yesterday at 1324.0. En route, price made both a “higher-low”, but also a “lower-high”, referred to by traders as an “inside week”. Fairly […]
